Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-08
2007-05-08
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S311000
Reexamination Certificate
active
11276649
ABSTRACT:
The present invention relates to new beta-agonists of general formula 1:wherein the groups R1to R12have the meanings given in the claims and specification, the isomers thereof, processes for preparing these compounds and their use as pharmaceutical compositions.
REFERENCES:
patent: 2943090 (1960-06-01), Semb et al.
patent: 3092636 (1963-06-01), Heinzelman et al.
patent: 4647563 (1987-03-01), Schromm et al.
patent: 2115926 (1972-10-01), None
patent: 0008653 (1980-03-01), None
patent: 0177245 (1986-04-01), None
patent: 1200886 (1970-08-01), None
patent: 2356197 (2001-05-01), None
patent: 9529159 (1995-11-01), None
patent: 9721665 (1997-06-01), None
Kawashima Kazu; Publication No. 08165276, Publication Date Jun. 25, 1996; 2-akylamino-1-phenylethanol derivative; Patent Abstract of Japan, vol. 1996, No. 10.
Robert Bruce Moffett; New Compounds with Possible Pharmacological Activity; Journal of Chemical and Engineering Data (1980), vol. 25, pp. 176-183; American Chemical Society.
James E. Clifton, et al; Arylethanolamines Derived from Salicylamide with alpha and beta-Adrenoceptor Blocking Activities. Preparation of Labetalol, Its Enantiomers, and Related Salicylamides; Journal of Medical Chemistry (1982), vol. 25, pp. 670-679; American Chemical Society.
Hamilton Bradford S.
Mueller Stephan Georg
Stenkamp Dirk
Trieselmann Thomas
Boehringer Ingelheim Pharma GmbH & Co. KG
Devlin Mary-Ellen M.
Morris Michael P.
Stempel Alan R.
Stockton Laura L.
LandOfFree
Beta-agonists, processes for preparing them and their use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Beta-agonists, processes for preparing them and their use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta-agonists, processes for preparing them and their use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3753633